Copyright
©The Author(s) 2015.
World J Diabetes. Jun 10, 2015; 6(5): 693-706
Published online Jun 10, 2015. doi: 10.4239/wjd.v6.i5.693
Published online Jun 10, 2015. doi: 10.4239/wjd.v6.i5.693
Ref. | Year | Diagnosis | UR-D | Total study patients | Location | Patient population |
Norhammer et al[45] | 2002 | OGTT | 51 (31%) at discharge36 (25%) at 3 mo | 164 144 | Multicentre (Sweden) | Post AMI, Hospital/ICU |
George et al[47] | 2005 | Fasting blood glucose ≥ 7 mmol/L | 13 (3%) | 427 | London, United Kingdom | Emergency Department |
Wexler et al[17] | 2008 | HbA1c > 6.5 | 33 (5%) | 695 | Boston, United States | Hospital |
Lankisch et al[46] | 2008 | OGTT | 31 (32%) at discharge19 (31%) at 3 mo | 96 62 | Wuppertal, Germany | Post AMI, Hospital/ICU |
Mazurek et al[18] | 2010 | HbA1c ≥ 6.5 | 152 (16%) | 971 | New York, United States | Hospital |
Feldman-Billard et al[16] | 2013 | Fasting blood glucose≥ 7 mmol/L | 156 (7%) | 2141 | Multicentre (France) | Hospital |
Plummer et al[34] | 2014 | HbA1c ≥ 6.5 | 55 (6%) | 1000 | Adelaide, Australia | ICU |
Hoang et al[44] | 2014 | HbA1c ≥ 6.5 | 14 (14%) | 102 | New Haven, United States | Medical ICU |
Ochoa et al[43] | 2014 | HbA1c ≥ 6.5 | 8 (9%) | 92 | Abilene, United States | Hospital |
- Citation: Kar P, Jones KL, Horowitz M, Deane AM. Management of critically ill patients with type 2 diabetes: The need for personalised therapy. World J Diabetes 2015; 6(5): 693-706
- URL: https://www.wjgnet.com/1948-9358/full/v6/i5/693.htm
- DOI: https://dx.doi.org/10.4239/wjd.v6.i5.693